CVE-2023-33241

CVE-2023-33241 is a critical-severity vulnerability in Gg18 Project Gg18 with a CVSS 3.x base score of 9.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-74.

Key facts

Description

Crypto wallets implementing the GG18 or GG20 TSS protocol might allow an attacker to extract a full ECDSA private key by injecting a malicious pallier key and cheating in the range proof. Depending on the Beta parameters chosen in the protocol implementation, the attack might require 16 signatures or more fully exfiltrate the other parties' private key shares.

Frequently asked questions

What is CVE-2023-33241?
Crypto wallets implementing the GG18 or GG20 TSS protocol might allow an attacker to extract a full ECDSA private key by injecting a malicious pallier key and cheating in the range proof. Depending on the Beta parameters chosen in the protocol implementation, the attack might require 16 signatures or more fully exfiltrate the other parties' private key shares.
How severe is CVE-2023-33241?
CVE-2023-33241 has a CVSS 3.x base score of 9.6, rated critical severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability none.
Is CVE-2023-33241 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (59th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-33241?
CVE-2023-33241 primarily affects Gg18 Project Gg18. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-33241?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2023-33241 published?
CVE-2023-33241 was published on 2023-08-09 and last updated on 2026-06-17.

References

Affected products (2)

Other CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities

Browse all CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities →